Compare Bajaj Finserv Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹500
₹100
Expense Ratio
2.39
1.87
NAV
₹9.19
₹37.61
Fund Started
06 Dec 2024
25 Jun 2018
Fund Size
₹314.74 Cr
₹6801.16 Cr
Exit Load
1% for redemption within 3 Months
Exit load of 1% if redeemed within 15 days.
1 Year
5.64%
8.17%
3 Year
-
27.53%
5 Year
-
16.59%
Equity
95.11%
97.98%
Cash
4.87%
1.99%
Top 10 Holdings
Divi's Laboratories Ltd. | 8.90% |
Sun Pharmaceutical Industries Ltd. | 7.90% |
Apollo Hospitals Enterprise Ltd. | 6.20% |
Aurobindo Pharma Ltd. | 6.01% |
Piramal Pharma Ltd. | 4.00% |
Emcure Pharmaceuticals Ltd. | 3.91% |
Cipla Ltd. | 3.72% |
Neuland Laboratories Ltd. | 3.60% |
Fortis Healthcare Ltd. | 3.33% |
Rubicon Research Ltd. | 3.33% |
Sun Pharmaceutical Industries Ltd. | 11.21% |
Cipla Ltd. | 9.40% |
Mankind Pharma Ltd. | 7.64% |
Dr. Reddy's Laboratories Ltd. | 6.52% |
Biocon Ltd. | 6.20% |
Divi's Laboratories Ltd. | 5.95% |
Lupin Ltd. | 3.99% |
Aurobindo Pharma Ltd. | 3.70% |
Alkem Laboratories Ltd. | 3.47% |
Syngene International Ltd. | 3.16% |
Name
-
-
Start Date
-
-
Description
The Scheme seeks to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
06 Dec 2024
25 Jun 2018
